( ) saw a notable increase in short interest during the month of April. On April 30, there were 75,500 short shares. This is a 57.3% increase from the total of 48,00 shares on April 15. The days-to-cover is currently 2.3 days based on an average trading of 32,800 share.
Reviva Pharmaceuticals trading down 1.8 %
The stock dropped $0.05 in the trading hours of Thursday to $2.67. The stock was traded at 14,363 shares, as opposed to the average of 30,142. Reviva Pharmaceuticals's 1-year low is $0.05, and its 1-year high is $3.00. A recent institutional investor increased its position in Reviva Pharmaceuticals. According to the latest Form 13F filed with the Securities & Exchange Commission, ) increased by 1.3% in the third quarter. The firm now owns 1,251,250 of the stock, after adding 16,250 additional shares in the last quarter. BlueCrest Capital Management Ltd held shares of Reviva Pharmaceuticals worth $239,000 by the end the last quarter.
MarketBeat.com offers a FREE daily email newsletter